
Shares of drugmaker AbbVie ABBV.N rise 1.09% to $228.13 premarket
Co reports Q4 adjusted profit of $2.71 per share vs. analysts' average estimate of $2.65, according to data compiled by LSEG
Expects FY 2026 adj. profit of $14.37 to $14.57 per share vs. analysts' average estimate of $14.24
Quarterly revenue of $16.62 billion beats analysts' average estimate of $16.42 billion
Shares rose ~29% in 2025